Publications by authors named "Caitlin Bourque"

10Publications

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.

J Clin Oncol 2018 07 9;36(19):1949-1956. Epub 2018 May 9.

Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Irina Ostrovnaya, Hikmat Al-Ahmadie, Maria E. Arcila, Jamie C. Riches, Andreas Meier, Caitlin Bourque, Maha Shady, Helen Won, Brooke E. Kania, Mariel E. Boyd, Catharine K. Cipolla, Ashley M. Regazzi, Asia S. McCoy, Hebert Alberto Vargas, Michael F. Berger, David B. Solit, Jonathan E. Rosenberg, and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center; Gopa Iyer, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Hikmat Al-Ahmadie, David B. Solit, and Dean F. Bajorin, Weill Cornell Medical College; Arjun V. Balar, William C. Huang, Samir S. Taneja, and Daniela Delbeau, New York University Langone Medical Center, New York, NY; and Matthew I. Milowsky, Michael Woods, Tracy L. Rose, and William Y. Kim, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.0158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049398PMC
July 2018

KIT Suppresses BRAF-Mutant Melanoma by Attenuating Oncogenic RAS/MAPK Signaling.

Cancer Res 2017 11 25;77(21):5820-5830. Epub 2017 Sep 25.

Program in Molecular Medicine, Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-17-0473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679278PMC
November 2017

Multiplexing of ChIP-Seq Samples in an Optimized Experimental Condition Has Minimal Impact on Peak Detection.

PLoS One 2015 11;10(6):e0129350. Epub 2015 Jun 11.

Department of Medicine, Division of Hematology/Oncology, Epigenomics Core Facility, Weill Cornell Medical College, New York, New York, United States of America; Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129350PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466019PMC
April 2016

RSK1 activation promotes invasion in nodular melanoma.

Am J Pathol 2015 Mar 8;185(3):704-16. Epub 2015 Jan 8.

The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York; Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2014.11.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348467PMC
March 2015

Hooked on zebrafish: insights into development and cancer of endocrine tissues.

Endocr Relat Cancer 2011 Oct 30;18(5):R149-64. Epub 2011 Aug 30.

Departments of Surgery and Medicine, Weill Cornell Medical College and New York Presbyterian Hospital, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-11-0099DOI Listing
October 2011

APC mutant zebrafish uncover a changing temporal requirement for wnt signaling in liver development.

Dev Biol 2008 Aug 20;320(1):161-74. Epub 2008 May 20.

Stem Cell Program and Hematology/Oncology, Children's Hospital and Dana-Farber Cancer Institute, HHMI, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2008.05.526DOI Listing
August 2008